Results 71 to 80 of about 281,748 (215)
American Journal of Hematology, Volume 100, Issue 11, Page 2017-2027, November 2025.A new risk model for essential thrombocythemia that is based on complete blood cell count‐derived parameters and host‐related factors. ABSTRACT Survival prediction models in essential thrombocythemia (ET) include the International Prognostic Scoring System (IPSET) and the more recently introduced triple‐A (AAA) prognostic score.
Ayalew Tefferi +21 more
wiley +1 more source
Cancer Reports, Volume 8, Issue 11, November 2025.ABSTRACT Background Myeloproliferative neoplasms (MPN) present significant management challenges as their constitutional symptoms greatly affect patients' quality of life. While current literature addresses hematological aspects, the full symptom burden and post‐clinic challenges for adult patients, especially in outpatient settings, remain unclear ...
Yating Liu +9 more
wiley +1 more source
Haematologica, 2011 We tested the hypothesis that levels of pentraxin high sensitivity C-reactive protein and pentraxin 3 might be correlated with cardiovascular complications in patients with essential thrombocythemia and polycythemia vera.
Tiziano Barbui +15 more
doaj +1 more source
Elucidating the etiology of idiopathic spontaneous intraperitoneal hemorrhage
Journal of Forensic Sciences, Volume 70, Issue 6, Page 2565-2571, November 2025.Abstract Free blood within the abdominal cavity (hemoperitoneum) presents a significant diagnostic and interpretive challenge. It may result from trauma or occur spontaneously in association with underlying disease conditions. When no source of fatal hemorrhage is identified, the implications extend across forensic, criminalistic, legal, and ethical ...
Dalibor Kovařík +4 more
wiley +1 more source
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis
Haematologica, 2019 Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk +2 more
doaj +1 more source
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment [PDF]
, 2022 Christina Schjellerup Eickhardt‐Dalbøge +15 more
openalex +1 more source
Haematologica, 2019 Hydroxyurea is the standard treatment in high-risk patients with polycythemia vera. However, estimates of its effect in terms of clinical outcomes (thrombosis, bleeding, hematologic transformations and mortality) are lacking. We performed a meta-analysis
A. Ferrari +7 more
semanticscholar +1 more source
Cell Proliferation, Volume 58, Issue 11, November 2025.CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far +4 more
wiley +1 more source
Transient Spinal Cord Ischemia as Presenting Manifestation of Polycythemia Vera
Case Reports in Neurology, 2011 Spinal arterial vascularization is supplied by a large anastomotic net, making spinal ischemic events far less common than ischemic cerebral strokes. Polycythemia vera, due to blood hyperviscosity and activated platelet aggregation, is associated with a ...
Sónia Costa +3 more
doaj +1 more source